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Abstract
Rotaviruses are a major cause of viral gastroenteritis in children. For accurate and sensitive 
detection of rotavirus RNA from stool samples by reverse transcription-polymerase chain reaction 
(RT-PCR), the extraction process must be robust. However, some extraction methods may not 
remove the strong RT-PCR inhibitors known to be present in stool samples. The objective of this 
study was to evaluate and compare the performance of six extraction methods used commonly for 
extraction of rotavirus RNA from stool, which have never been formally evaluated: the MagNA 
Pure Compact, KingFisher Flex and NucliSENS® easyMAG® instruments, the NucliSENS® 
miniMAG® semi-automated system, and two manual purification kits, the QIAamp Viral RNA kit 
and a modified RNaid® kit. Using each method, total nucleic acid or RNA was extracted from 
eight rotavirus-positive stool samples with enzyme immunoassay optical density (EIA OD) values 
ranging from 0.176 to 3.098. Extracts prepared using the MagNA Pure Compact instrument 
yielded the most consistent results by qRT-PCR and conventional RT-PCR. When extracts 
prepared from a dilution series were extracted by the 6 methods and tested, rotavirus RNA was 
detected in all samples by qRT-PCR but by conventional RT-PCR testing, only the MagNA Pure 
Compact and KingFisher Flex extracts were positive in all cases. RT-PCR inhibitors were detected 
in extracts produced with the QIAamp Viral RNA Mini kit. The findings of this study should 
prove useful for selection of extraction methods to be incorporated into future rotavirus detection 
and genotyping protocols.
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Group A rotaviruses are well established as the major cause of acute viral gastroenteritis in 
infants and young children worldwide. Rotaviruses belong to the Reoviridae family and 
possess a genome of 11 segments of double-stranded RNA (dsRNA). The binomial 
classification system for rotaviruses is based on the two outer capsid proteins, VP7 (G 
genotype) and VP4 (P genotype) (Estes and Kapikian, 2007). At least 27 G and 35 P 
genotypes have been designated for human and animal strains (Matthijnssens et al., 2011). 
Five strains, G1P1A[8], G2P1B [4] G3P1A[8], G4P1A[8], and G9P1A[8] are the globally 
predominant human pathogens (Gentsch et al., 2005) and have been targeted in vaccine 
development.
Two live-attenuated oral vaccines, RotaTeq® (Merck, Whitehouse Station, NJ, USA) and 
Rotarix® (GlaxoSmithKline, Research Triangle Park, NC, USA) have been introduced into 
childhood immunization programs in the United States and other countries (Glass et al., 
2006). RotaTeq® is a pentavalent human-bovine reassortant rotavirus vaccine that includes 
genes of human rotavirus serotypes G1-G4 and P1A[8]. Rotarix® vaccine is a monovalent 
vaccine derived from a G1P1A[8] human rotavirus strain. Transmission and shedding of 
rotavirus vaccine strains has been reported (Donato et al., 2012; Payne et al., 2010; Rivera et 
al., 2011; Yen et al., 2011).
To monitor circulating rotavirus serotypes before and after vaccine introduction, including 
any possible emerging or novel strains post-vaccine introduction, many countries conduct 
regional rotavirus strain surveillance programs. In the United States, surveillance by the 
Centers for Disease Control and Prevention (CDC), in collaboration with laboratories of the 
National Rotavirus Strain Surveillance System (NRSSS) (Griffin et al., 2000; 
Ramachandran et al., 1998), and the New Vaccine Surveillance Network (Payne et al., 
2008), has been ongoing since 1996 and 2006, respectively.
Rotavirus strain surveillance programs typically use reverse transcription-polymerase chain 
reaction (RT-PCR)-based methods to determine rotavirus genotypes directly from RNA 
extracted from stool specimens (Das et al., 1994; Gentsch et al., 1992; Gouvea et al., 1990) 
and rotavirus detection by real time RT-PCR (qRT-PCR) is increasing in use (Freeman et 
al., 2008). Fecal samples are among the most difficult clinical samples to process because of 
the presence of very potent inhibitors of nucleic acid amplification such as complex 
polysaccharides, bilirubin and bile salts (Chiu and Ou, 1996; Monteiro et al., 1997; Pandey 
et al., 1996). Difficulty in eliminating RT-PCR inhibitors from stool extracts has been 
reported extensively (Lantz et al., 1997; Makristathis et al., 1998; Monteiro et al., 1997; 
Petrich et al., 2006). Inhibitory effects can be reduced by adding amplification facilitators 
such as bovine serum albumin to the PCR reaction (Kreader, 1996), using thermostable 
polymerases that are more resistant to PCR inhibition (Abu Al-Soud and Radstrom, 1998), 
or using more efficient processes for extracting nucleic acid from stool samples. The 
efficiency of nucleic acid extraction and purification influences the sensitivity, 
reproducibility and the accuracy of RT-PCR target detection (Lim et al., 2005). During the 
last 10 years, several new manual, semi-automated and automated commercial nucleic acid 
or RNA extraction systems using magnetic beads or silica particles have been developed for 
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DNA, RNA or total nucleic acid extraction which are attractive due to their flexibility, 
convenience, and ease of use (Tang et al., 2005a). A small number of studies have compared 
some of these novel extraction methods and reported that they differ in their ability to 
recover viral RNA, indicating that no single RNA extraction method is optimal for all 
viruses (Baert et al., 2007; Hale et al., 1996; Kok et al., 2000; Petrich et al., 2006).
The most recent study comparing nucleic acid extraction methods for rotavirus detection in 
stool was published in 2002 (Rasool et al., 2002). Since then, a number of new nucleic acid 
extraction systems using magnetic beads or silica particles have been developed, both in 
automated and manual formats (Dundas et al., 2008b; Perelle et al., 2009; Schuurman et al., 
2007; Tang et al., 2005b). Although some of these extraction systems have been used 
extensively for the extraction of rotavirus RNA from stool and other clinical and 
environmental samples (Banyai et al., 2011; Doan et al., 2011; Esona et al., 2010a; Esona et 
al., 2010b; Freeman et al., 2008; Hull et al., 2011; Matthijnssens et al., 2006; Rahman et al., 
2010; Rahman et al., 2007a; Rahman et al., 2007b; Zeller et al., 2010), they have not been 
evaluated formally to determine which method is most efficient for extraction of rotavirus 
RNA.
The objective of this study was to identify the best commercially-available nucleic acid 
extraction method for preparing stool samples for detection of rotaviruses by both 
conventional RT-PCR and qRT-PCR. This information will be very useful for rotavirus 
surveillance programs, diagnostics, and epidemiologic studies.
Materials and Methods
Stool samples
Eight rotavirus positive stool samples with optical density (OD) values ranging from 0.176 
to 3.098 , as determined by enzyme immunoassay (EIA) (Premier™ RotaClone®, Meridian 
Bioscience, Cincinnati, OH, USA), were used to prepare 10% suspensions in phosphate-
buffered saline solution. These samples (5627:EIA OD=0.854, genotype G2P[4]; 
5628:OD=0.176, G2P[4]; 5629:OD=0.547, G2P[4]; 5630:OD=3.098, G4P[8]; 
5631:OD=2.075, G4P[8]; 5633:OD=1.768, G2P[4]; 5634:OD=0.318, G1P[8]; and 
5635:OD=0.315, G1P[8]) were collected in Nicaragua during the 2009 rotavirus season.
Extraction methods
Six commercial extraction methods for total nucleic acid or RNA were evaluated: the 
automated MagNA Pure Compact (Roche Applied Science, Indianapolis, IN, USA), 
KingFisher Flex-96 (ThermoFisher, Pittsburgh, PA, USA), and NucliSENS® easyMAG® 
(BioMerieux, Durham, NC, USA) methods; the semi-automated NucliSENS® miniMAG® 
(BioMerieux, Durham, NC, USA); and the manual QIAamp Viral RNA mini kit 
(Qiagen,Valencia, CA, USA) and RNaid® kit (Qbiogene, Carlsbad, CA, USA) with a 
modified protocol) (Table 1). Each extraction method was chosen because it had been used 
previously in studies for the extraction of nucleic acid from stool. The MagNA Pure LC 
instrument has been used to purify nucleic acid from many types of clinical specimens 
including stool samples for rotavirus (Dalesio et al., 2004; Petrich et al., 2006; Schmid et al., 
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2004; Wolk et al., 2002; Wu et al., 2011) but is no longer in production so the MagNA Pure 
Compact instrument, which uses the same paramagnetic bead technology, was evaluated 
instead . The MagNA Pure Compact was used with the MagNA Pure Compact RNA 
Isolation Kit (Roche Applied Science Indianapolis, IN, USA). The easyMAG and miniMAG 
extraction platforms utilize the same silica extraction technology and use the same reagents. 
Both methods are universal and can be applied to a broad range of different specimens such 
as blood, sputum, serum, throat swabs and stool (Dundas et al., 2008a; Freeman et al., 2008; 
Loens et al., 2008; Perelle et al., 2009; Tang et al., 2005b). Both methods have been used for 
extraction of rotavirus RNA from stool (Hull et al., 2011). The easyMAG and miniMAG are 
mainly used in laboratories that require moderate- and low-throughput, respectively (Yang 
et al., 2011). The KingFisher Flex (96 deep well magnet head) designed for high throughput 
laboratories, is an automated extractor also used for rotavirus RNA extraction (Freeman et 
al., 2008; Grant et al., 2011; Hull et al., 2011). In this study it was used with the MagMax™- 
96 Total RNA Isolation Kit (Applied Biosystems, Foster City, CA, USA). The QIAamp 
Viral RNA Mini kit, which is based on silica membrane technology, has been used 
extensively for the extraction of rotavirus RNA from stool (Doan et al., 2011; Matthijnssens 
et al., 2006; Rahman et al., 2007a; Rahman et al., 2007b; Zeller et al., 2010).
The RNaid kit extraction protocol, which uses glass powder to capture and purify rotavirus 
RNA, has been modified and used by the CDC Rotavirus Surveillance Laboratory routinely 
since the 1990’s along with other methods to extract rotavirus RNA from stool. (Gentsch et 
al., 1992; Jothikumar et al., 2009). In brief, 200 −L of clarified 10% stool suspension was 
mixed directly with 400 −L 6M guanidine thiocyanate (Ultrapure Grade; Boehringer 
Mannheim, Germany) and 10 −L of RNAID glass powder. The mixture was then vortexed 
and mixed on a Nutator rocker (Clay Adams Division, Becton-Dickinson, Parsippany, NJ, 
USA) for 15 min at room temperature. Each sample was then centrifuged for 60 s at 650 × g 
and the supernatant was removed by aspiration with a Pasteur pipette. The samples were 
washed once with 700 −L of guanidine thiocyanate wash solution (4 M guanidine 
thiocyanate, 16.7 mM Tris-HCl, pH 7.5) and centrifuged at 850 × g for 60 s. The supernatant 
was aspirated and the samples were then washed two times with 400 −L of the RNAID kit 
wash buffer and centrifuged at 850 × g for 60 s. The supernatant was aspirated, and the 
samples were washed once more with the same buffer and were then finally centrifuged at 
10,000 × g for 120 s. After aspiration of the supernatant, the samples were dried at room 
temperature for 1 hour, resuspended in 35 −L of nuclease free water, and incubated for 10 
min at 65°C. The samples were centrifuged at 10,000 × g for 120 s, and the supernatant was 
transferred to microcentrifuge tubes (Lube Tube; Marsh Co., Rochester NY, USA). The 
pellet was re-extracted with the same volume of water (35 −L), and the combined 
supernatants were stored at −80°C until they were used. Immediately before use for PCR, 
the supernatants were incubated at 56°C for 5 min and were then centrifuged at 10,000 × g 
for 60 s to pellet the residual RNAID from the sample.
With the exception of the RNaid kit as described, extractions were performed according to 
kit and instrument protocols. Single aliquots of each stool suspension and a negative control 
stool were extracted in triplicate by each method.
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The total nucleic acid or RNA extracts were amplified in duplicate by rotavirus NSP3 gene 
qRT-PCR (Freeman et al., 2008) modified for use on ABI 7500 Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA) with the 7500 Fast SDS software 
v1.4.0. No-template and positive controls were included in each run. All assays were run 
using the standard mode on the ABI 7500 Fast instrument. Before beginning the TaqMan 
cycling conditions, each RNA extract was first denatured in a thermocycler at 95°C for 5 
min followed by a 1 min incubation on ice. The thermocycling program used was 30 min 
reverse transcription at 50°C (1 cycle), followed by a 15 min enzyme deactivation step at 
95°C (1 cycle), and 45 cycles of amplification that consisted of denaturation at 95°C for 15 
sec and annealing and extension at 60°C for 1 min.
To test for potential carryover of RT-PCR inhibitors from the stool samples into total 
nucleic acid or RNA extracts, extracts from three stool samples were diluted 1:10 in 
nuclease free water and re-tested in duplicate by qRT-PCR as previously described by 
Petrich et al (Petrich et al., 2006).
Comparison of dilution series extracts by conventional RT-PCR and qRT-PCR
A 10% suspension prepared from stool sample with a high viral concentration (OD value 
3.098) was serially diluted 10−1 to 10−7 in a rotavirus-negative stool suspension and then re-
tested by EIA. Total nucleic acid or RNA was extracted by each of the six methods and 
tested by VP6 RT-PCR and NSP3 qRT-PCR (Freeman et al., 2008; Iturriza Gomara et al., 
2002). For the real-time assay, each dilution was tested in duplicate and the average 
threshold cycle (Ct) value for each reaction was calculated. VP6 RT-PCR amplicons were 
detected by electrophoresis of the amplified products through 1% agarose gels containing 
GelRed (Biotium, Heyward, CA, USA) and RT-PCR products were detected under UV 
transillumination.
Cost and time analysis
Extraction cost per sample was estimated using the 2012 manufacturer price of each 
extraction kit or reagents. Hands-on time for the MagNA Pure Compact system, miniMAG 
system, RNaid kit, and QIAamp Viral RNA Mini was measured as time per sample when 
eight extractions were performed in parallel. Also, the easyMAG and KingFisher Flex 
systems were timed using a run of eight samples. For all methods, operator’s hands-on time 
was measured as the total time to perform each step in the extraction process. Total time to 
completion (hands-on and hands-off) was determined by timing a complete run on each 
instrument, from the addition of the first reagent to the recovery of the RT-PCR-ready 
nucleic acid.
Statistical analysis
Prism Version 5.02 Software for Windows (GraphPad Software, La Jolla CA) was used to 
plot Ct values. To determine whether the differences in Ct values for nucleic acid extracts 
prepared using each extraction method were significant, Ct values were compared using the 
Friedman test. When significant differences were identified, Dunn’s Multiple Comparison 
Test was used to perform nonparametric pairwise analyses of Ct values.
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Comparison of extraction methods by qRT-PCR
When qRT-PCR results were compared for all six extraction methods, samples extracted by 
using the MagNA Pure Compact system yielded the lowest average Ct values for 6 of 8 
stools, including the 5 highest concentration samples as determined at EIA; the RNaid 
performed best with the other two samples which were among the 3 lowest concentration 
samples as determined by EIA (Fig. 1). Statistical analysis of method-to-method variability 
detected significant differences among the mean Ct values for all nucleic acid extracts 
obtained using the 6 methods (P < 0.001). When pairwise analyses of extraction method data 
were performed, the mean Ct values for KingFisher Flex extracts were significantly higher 
than those of the best performing method (MagNA Pure Compact or RNaid kit) for 7 of 8 
samples as was the case for the QIAamp Viral RNA Mini kit with 6 samples (Fig. 1). In the 
case of 4 samples (5630, 5631, 5627, 5629) where the MagNA Pure Compact extracts 
yielded the lowest mean Ct values, the values for the RNaid kit were significantly higher 
(Fig. 1). In the two cases where the RNaid kit extracts yielded the lowest mean Ct values 
(samples 5634 and 5628), the mean Ct values for the MagNA Pure Compact extracts were 
not significantly different. With 2 samples (5634, 5635), the mean Ct values for miniMAG 
extracts were significantly higher than the best performing method. The mean Ct values for 
the easyMAG were never the lowest but never differed significantly from the best 
performing method.
Inhibitors were detected in extracts prepared with the QIAamp Viral RNA Mini kit; the 1:10 
dilutions of each QIAamp Viral RNA Mini kit extract exhibited lower Ct values than the 
undiluted extract (Table 2), with average Ct values decreasing 1.3 to 2.5 cycles. The 1:10 
dilutions of the extracts prepared using the other extraction methods showed increases in Ct 
values by 2 to 4 cycles, consistent with a dilution effect of target RNA.
Comparison of dilution series extracts by conventional RT-PCR and qRT-PCR
Extracts from serially diluted stool samples were analyzed for the presence of the template 
using VP6 RT-PCR (Iturriza Gomara et al., 2002) and the NSP3 qRT-PCR assay (Freeman 
et al., 2008). For the conventional RT-PCR assay, analysis by gel electrophoresis revealed a 
single band of the expected size for all rotavirus samples (Fig. 2). MagNA Pure Compact 
and KingFisher Flex were the only platforms capable of producing amplifiable template 
from all 7 dilutions (10−1 to 10−7). The QIAamp Viral RNA kit, and miniMAG systems 
yielded amplifiable template in 5 out of the 7 dilutions (10−1 to 10−5). The RNaid® kit and 
easyMAG® system yielded template with the poorest level of detection with template 
detected in the first 3 dilutions (10−1 to 10−3) only. With the qRT-PCR, the Ct values 
obtained with each method increased with each sample dilution and all rotavirus RNA was 
detected in all dilutions for all six extraction methods (Table 3) but there were significant 
differences in Ct values among the six methods (P<0.0001). Ct values obtained from extracts 
prepared using the RNaid® kit were significantly lower than those obtained for the 
easyMAG®, miniMAG®, and QIAamp Viral Mini RNA kit extracts (Table 3). Extracts 
prepared using the KingFisher Flex yielded Ct values that were significantly lower than 
those obtained from easyMAG® and miniMAG® extracts (Table 3). Ct values obtained 
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from extracts prepared using the MagNA Pure Compact were significantly lower than those 
obtained for the miniMAG® (Table 3). Extracts prepared using the RNaid® kit, MagNA 
Pure Compact and KingFisher Flex did not differ significantly (Table 3).
Cost and time analysis
The total extraction time for 8 samples ranged from approximately 40 min for QIAamp 
Viral RNA Mini kit and KingFisher Flex to approximately 110 min for the RNaid kit (Table 
4). The RNaid kit had the lowest cost/per sample and MagNA Pure Compact was the most 
expensive. The KingFisher Flex had the highest sample throughput (up to 96 samples/run).
Discussion
Evaluation of the six commercial extraction platforms using stool samples indicated that the 
MagNA Pure Compact performed best for isolating rotavirus RNA that could be amplified 
by both conventional RT-PCR and qRT-PCR. No PCR inhibitors were detected in the 
extracts, which most often yielded the lowest Ct values. Although it is the most costly, this 
method was the most consistent and had relatively low hands-on and hands-off time 
processing time. Without knowledge of the proprietary components of the kit used with 
MagNA Pure Compact RNA Isolation kit, the reason for its superior performance cannot be 
determined. However, a possible explanation is that the method uses silica-coated magnetic 
beads, and the extraction process includes a DNase treatment step. The easyMAG, 
miniMAG and KingFisher Flex methods also use magnetic beads but without a DNase 
treatment step. The Ct values for extracts obtained using these methods were always higher 
but the extracts were not found to contain inhibitors of RT-PCR. The easyMAG and 
miniMAG extraction platforms are total nucleic acid extraction methods, suggesting that 
DNA in the extracts may have interfered with the extraction process or RT-PCR. The 
KingFisher Flex is an RNA only extraction method, but without a DNase treatment step the 
extracted product is likely to be contaminated with DNA. Therefore, the sub-optimal 
performance of the KingFisher Flex may be a function of the small volume of sample 
processed (50 −L) as well as the presence of DNA in the extract.
The QIAamp Viral Mini RNA kit yielded extracts with mean Ct values which were 
significantly higher than the best performing method with 6 samples. This study showed that 
use of the QIAamp Viral RNA Mini kit can lead to carryover of RT-PCR inhibitors for 
rotavirus RNA detection, since the 1:10 dilution of extracts lowered the Ct values. Detection 
of partial amplification inhibition has been reported for stool samples extracted using the 
QIAamp Viral RNA kit when stool extracts were tested for SARS coronavirus RNA (Petrich 
et al., 2006). The rest of the extraction methods showed no notable inhibition, only an 
expected dilution effect which results in an increase in Ct values.
When a dilution series of rotavirus positive stool diluted in a negative stool was extracted by 
each of the six methods and then tested by qRT-PCR, rotavirus RNA was detected in all 
samples. When each set of extracts from the dilution series was tested by conventional RT-
PCR assays, however, only the MagNA Pure Compact and KingFisher Flex extracts were 
able to yield a detectable product in all seven dilutions. This observation could be the result 
of differences in amplicon size between the two methods, 91 base-pairs for qRT-PCR versus 
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379 bp for conventional RT-PCR. Rotavirus RNA extracted by using the RNaid kit may be 
sheared or somehow damaged by the manual extraction procedure of this kit with reduced 
detection efficiency of larger RNA molecules. Automated methods such as the MagNA Pure 
Compact and KingFisher Flex may damage RNA less than manual methods. Although 
limitations for detection at low virus concentrations may not be of concern when testing 
samples from persons with acute rotavirus gastroenteritis, from whom rotavirus typically is 
shed at very high concentrations in stool (approximately 1010 to 1011 particles/gram of 
stool) (Ray et al., 2006), this limitation would be important when choosing a method to 
extract samples from convalescent cases or healthy controls in which the viral concentration 
would be expected to be much lower.
Two limitations of this study should be noted. Because of the differences in extraction 
products (total nucleic acid or RNA), as well the presence of carrier RNA in the QIAamp 
Viral Mini RNA kit extracts, no attempt was made to measure directly and compare the 
quantity of the nucleic acid in the sample extracts tested. Also, no internal positive control 
was included in the extractions. Another limitation of this study was the lack of an 
encapsulated RNA control that could be spiked into stool, without RNA degradation by 
nucleases present in feces, and detected post-extraction by qRT-PCR and RT-PCR. Efforts 
to develop such a control are currently underway.
In summary, this study reports the most extensive evaluation to date of extraction platforms 
for the purification of rotavirus RNA from stool samples. The findings of this study will be 
very useful for laboratories in the selection of extraction methods for detection of rotavirus 
RNA in stool and the development of future protocols for rotavirus testing and surveillance.
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Scatter plots showing the distribution of Ct values obtained using RNA or total nucleic acid 
prepared from eight rotavirus samples using six different extraction protocols. The 
horizontal line in each group of observed values for a method corresponds to the mean 
value. Sample ID and OD values (in parentheses) are indicated above each scatter plot 
graph. T-bars indicate the standard deviation of the mean. The best performing method for 
each sample is labeled with a ★.
Methods with mean Ct values that were found to be significantly higher than the best 
performing method are labeled with * (P < 0.05), ** (P<0.01), or *** (P<0.001).
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Gels showing limit of detection of rotavirus VP6 gene fragment (379 bp) by conventional 
RT-PCR using RNA or total nucleic acid extracted from a stool sample containing a high 
concentration of rotavirus (EIA OD value = 3.0) diluted 10−1 to 10−7 in a negative stool 
suspension, by each extraction method. A= MagNA Pure Compact, B= KingFisher Flex, C= 
QIAamp Viral RNA, D= miniMAG®, E= easyMAG® and F= RNaid®. MM= 100 bp Plus 
DNA Ladder.
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Table 4












RNaid® ~110 ~50 ~60 0.87 n/a
QIAamp Viral
RNA Mini Kit
~40 ~30 ~10 3.94 n/a
MagNa Pure
Compact
~80 ~20 ~60 10.75 8
KingFisher
Flex
~85 ~55 ~30 3.48 96
easyMAG® ~71 ~25 ~46 8.84 24
miniMAG® ~72 ~57 ~15 6.3 12
a
Cost calculated in 2012
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